{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:17Z","timestamp":1791478337106,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02634-y","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:35:02Z","timestamp":1791387302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum melatonin levels and their relationship with inflammation and oxidative stress in patients with diabetic nephropathy: a cross-sectional case\u2013control study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7582-5520","authenticated-orcid":false,"given":"Emel","family":"Tatl\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-4314","authenticated-orcid":false,"given":"Tu\u011fba","family":"Kip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2634_CR1","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","volume":"1","author":"MC Thomas","year":"2015","unstructured":"Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KA, Zoungas S, et al. Diabetic kidney disease. Nat Rev Dis Primers. 2015;1:15018.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2634_CR2","doi-asserted-by":"publisher","first-page":"e030821192521","DOI":"10.2174\/1573399817666210309104203","volume":"18","author":"K Nellaiappan","year":"2022","unstructured":"Nellaiappan K, Preeti K, Khatri DK, Singh SB. Diabetic complications: an update on pathobiology and therapeutic strategies. Curr Diabetes Rev. 2022;18(1):e030821192521.","journal-title":"Curr Diabetes Rev"},{"issue":"23","key":"2634_CR3","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.3390\/jcm12237349","volume":"12","author":"SK Sinha","year":"2023","unstructured":"Sinha SK, Nicholas SB. Pathomechanisms of diabetic kidney disease. J Clin Med. 2023;12(23):7349.","journal-title":"J Clin Med"},{"issue":"1","key":"2634_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/1354750X.2018.1501761","volume":"24","author":"SA Fathy","year":"2019","unstructured":"Fathy SA, Mohamed MR, Ali MA, El-Helaly AE, Alattar AT. Influence of IL-6, IL-10, IFN-\u03b3 and TNF-\u03b1 genetic variants on susceptibility to diabetic kidney disease in type 2 diabetes mellitus patients. Biomarkers. 2019;24(1):43\u201355.","journal-title":"Biomarkers"},{"issue":"2","key":"2634_CR5","first-page":"1934578X2513217","volume":"20","author":"Y Chen","year":"2025","unstructured":"Chen Y, Liu X, Shengbu M, Shi Q, Jiaqiu S, Lai X. Biomarkers: new advances in diabetic nephropathy. Nat Prod Commun. 2025;20(2):1934578X251321758.","journal-title":"Nat Prod Commun"},{"key":"2634_CR6","doi-asserted-by":"publisher","first-page":"120612","DOI":"10.1016\/j.lfs.2022.120612","volume":"301","author":"RJ Reiter","year":"2022","unstructured":"Reiter RJ, Sharma R, Rosales-Corral S, de Campos Zuccari DAP, de Almeida Chuffa LG. Melatonin: a mitochondrial resident with a diverse skill set. Life Sci. 2022;301:120612.","journal-title":"Life Sci"},{"issue":"4","key":"2634_CR7","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/ijms23041971","volume":"23","author":"R Hardeland","year":"2022","unstructured":"Hardeland R. Melatonin and the programming of stem cells. Int J Mol Sci. 2022;23(4):1971.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2634_CR8","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/ijms17122124","volume":"17","author":"DX Tan","year":"2016","unstructured":"Tan DX, Manchester LC, Qin L, Reiter RJ. Melatonin: a mitochondrial targeting molecule involving mitochondrial protection and dynamics. Int J Mol Sci. 2016;17(12):2124.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2634_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/molecules23020509","volume":"23","author":"RJ Reiter","year":"2018","unstructured":"Reiter RJ, Tan DX, Rosales-Corral S, Galano A, Zhou XJ, Xu B. Mitochondria: central organelles for melatonin\u2019s antioxidant and anti-aging actions. Molecules. 2018;23(2):509.","journal-title":"Molecules"},{"key":"2634_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.clnesp.2024.07.015","volume":"63","author":"RM Fard","year":"2024","unstructured":"Fard RM, Rashno M, Bahreiny SS. Effects of melatonin supplementation on markers of inflammation and oxidative stress in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2024;63:530\u20139.","journal-title":"Clin Nutr ESPEN"},{"issue":"5","key":"2634_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1590\/2359-3997000000098","volume":"59","author":"S Sharma","year":"2015","unstructured":"Sharma S, Singh H, Ahmad N, Mishra P, Tiwari A. The role of melatonin in diabetes: therapeutic implications. Arch Endocrinol Metab. 2015;59(5):391\u20139.","journal-title":"Arch Endocrinol Metab"},{"issue":"3","key":"2634_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tem.2019.11.011","volume":"31","author":"M Garaulet","year":"2020","unstructured":"Garaulet M, Qian J, Florez JC, Arendt J, Saxena R, Scheer FAJL. Melatonin effects on glucose metabolism: time to unlock the controversy. Trends Endocrinol Metab. 2020;31(3):192\u2013204.","journal-title":"Trends Endocrinol Metab"},{"key":"2634_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.biochi.2022.01.001","volume":"202","author":"R Patel","year":"2022","unstructured":"Patel R, Parmar N, Palit SP, Rathwa N, Ramachandran A, Begum R. Diabetes mellitus and melatonin: where are we? Biochimie. 2022;202:2\u201314.","journal-title":"Biochimie"},{"issue":"2","key":"2634_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.dsx.2014.09.018","volume":"9","author":"D Zephy","year":"2015","unstructured":"Zephy D, Ahmad J. Type 2 diabetes mellitus: role of melatonin and oxidative stress. Diabetes Metab Syndr. 2015;9(2):127\u201331.","journal-title":"Diabetes Metab Syndr"},{"issue":"1\u20132","key":"2634_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1440-1681.2006.04330.x","volume":"33","author":"F Oktem","year":"2006","unstructured":"Oktem F, Ozguner F, Yilmaz HR, Uz E, D\u00fcndar B. Melatonin reduces urinary excretion of N-acetyl-\u03b2-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats. Clin Exp Pharmacol Physiol. 2006;33(1\u20132):95\u2013101.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2634_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12986-019-0419-7","volume":"17","author":"H Ebaid","year":"2020","unstructured":"Ebaid H, Bashandy SAE, Abdel-Mageed AM, Al-Tamimi J, Hassan I, Alhazza IM. Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress. Nutr Metab (Lond). 2020;17:6.","journal-title":"Nutr Metab (Lond)"},{"issue":"4","key":"2634_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/ckj\/sfz198","volume":"13","author":"B Afsar","year":"2020","unstructured":"Afsar B, Elsurer Afsar R, Sag AA, Kanbay A, Korkmaz H, Cipolla-Neto J, et al. Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy. Clin Kidney J. 2020;13(4):522\u201330.","journal-title":"Clin Kidney J"},{"issue":"6","key":"2634_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/cells12060838","volume":"12","author":"M Markowska","year":"2023","unstructured":"Markowska M, Niemczyk S, Romejko K. Melatonin treatment in kidney diseases. Cells. 2023;12(6):838.","journal-title":"Cells"},{"issue":"1","key":"2634_CR19","first-page":"22","volume":"15","author":"M Satari","year":"2021","unstructured":"Satari M, Bahmani F, Reiner Z, Soleimani A, Aghadavod E, Kheiripour N, et al. Metabolic and anti-inflammatory response to melatonin administration in patients with diabetic nephropathy. Iran J Kidney Dis. 2021;15(1):22\u201330.","journal-title":"Iran J Kidney Dis"},{"key":"2634_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40795-025-01026-0","volume":"11","author":"S Sadeghi","year":"2025","unstructured":"Sadeghi S, Hakemi MS, Pourrezagholie F, et al. Effects of melatonin supplementation on oxidative stress and inflammatory biomarkers in diabetic patients with chronic kidney disease: a double-blind, randomized controlled trial. BMC Nutr. 2025;11:25.","journal-title":"BMC Nutr"},{"key":"2634_CR21","doi-asserted-by":"publisher","first-page":"1285509","DOI":"10.3389\/fendo.2023.1285509","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Wang L, Liu M, Zhou H, Xu H. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study. Front Endocrinol. 2024;14:1285509.","journal-title":"Front Endocrinol"},{"key":"2634_CR22","doi-asserted-by":"publisher","first-page":"205031212211402","DOI":"10.1177\/20503121221140231","volume":"10","author":"MZ Gurmu","year":"2022","unstructured":"Gurmu MZ, Genet S, Gizaw ST, Feyisa TO, Gnanasekaran N. Neutrophil\u2013lymphocyte ratio as an inflammatory biomarker of diabetic nephropathy among type 2 diabetes mellitus patients: a comparative cross-sectional study. SAGE Open Med. 2022;10:20503121221140231.","journal-title":"SAGE Open Med"},{"issue":"2","key":"2634_CR23","first-page":"216","volume":"61","author":"S Mihai","year":"2025","unstructured":"Mihai S, Cardoneanu A, Pinzariu AC, et al. Inflammatory markers as predictors of diabetic nephropathy in type 2 diabetes mellitus: a systematic review and meta-analysis. Med (Kaunas). 2025;61(2):216.","journal-title":"Med (Kaunas)"},{"issue":"4","key":"2634_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37(4):277\u201385.","journal-title":"Clin Biochem"},{"issue":"12","key":"2634_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103\u201311.","journal-title":"Clin Biochem"},{"issue":"17","key":"2634_CR26","doi-asserted-by":"publisher","first-page":"13541","DOI":"10.3390\/ijms241713541","volume":"24","author":"P Goycheva","year":"2023","unstructured":"Goycheva P, Petkova-Parlapanska K, Georgieva E, Karamalakova Y, Nikolova G. Biomarkers of oxidative stress in diabetes mellitus with diabetic nephropathy complications. Int J Mol Sci. 2023;24(17):13541.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"2634_CR27","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc26-S002","volume":"49","author":"American Diabetes Association","year":"2026","unstructured":"American Diabetes Association. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026. Diabetes Care. 2026;49(Suppl 1):S27\u201349.","journal-title":"Diabetes Care"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02634-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:10Z","timestamp":1791475390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02634-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2634"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02634-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Clinical Research Ethics Committee of Gaziosmanpa\u015fa Training and Research Hospital (Approval No: 16, Date: 15.03.2023; original applicant: Tu\u011fba Kip). All participants provided written informed consent prior to enrolment. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"311"}}